Additionally, in patients diagnosed with non-small cell lung cancer, ctDNA has been shown to predict overall survival in patients treated with PD-L1 blockade or with chemotherapy, in addition to revealing valuable tumor genetic information (48). The gene discussed is CD274; the disease is non-small cell lung carcinoma.